T.-L. Shih et al. / Tetrahedron Letters 45 (2004) 5751–5754
5753
199–210; (d) Look, G. C.; Fotsch, C. H.; Wong, C.-H.
Acc. Chem. Res. 1993, 26, 182–190; (e) Ganem, B. Acc.
Chem. Res. 1996, 29, 340–347; (f) Hudlicky, T.; Entwistle,
D. A.; Pitzer, K. K.; Thorpe, A. J. Chem. Rev. 1996, 96,
1195–1220; (g) Bols, M. Acc. Chem. Res. 1998, 31, 1; (h)
Sears, P.; Wong, C.-H. Angew. Chem., Int. Ed. 1999, 38,
2301–2324; (i) Lillelund, V. H.; Jensen, H. H.; Liang, X.;
Bols, M. Chem. Rev. 2002, 102, 515–554.
of 9 could eliminate the pale yellow color during the
subsequent purifications. A two-step conversion of 10
by oxidative cleavage with NaIO4 then reduced with
NaBH3CN afforded 1117 in 76% yield. Thus compound
11 was allowed to be hydrogenated in 6 N HCl over Pd/
C to provide the required azasugar 218 in 85% yield.
The structure of 2 was elucidated by HMBC and
HMQC experiments and the stereochemistry of H5 rel-
ative H2/H3 was further confirmed by no NOE obser-
vance of NOESY spectrum. Furthermore, efforts have
been made to synthesize 13, the enantiomer of 1, from
mesylation of 6 by the same manner of preparation of 2.
Unfortunately, it was proven fruitless. A tiny amount of
12 was received and most of 6 was recovered.
2. (a) Daigo, K.; Inamori, Y.; Takemoto, T. Chem. Pharm.
Bull. 1986, 34, 2243–2246; (b) Hughes, A. B.; Rudge, A. J.
Nat. Prod. Rep. 1994, 11, 135–162.
3. (a) Fellows, L. E.; Bell, E. A.; Lynn, D. G.; Pilkiewicz, F.;
Miura, I.; Nakanishi, K. J. Chem. Soc., Chem. Commun.
1979, 977–978; (b) Fuhrmann, U.; Bause, E.; Legler, G.;
Ploegh, H. Nature 1984, 307, 755–758; (c) Evans, S. V.;
Fellows, L. E.; Shing, T. K. M.; Fleet, G. W. J.
Phytochemistry 1985, 24, 1953–1955.
4. Kato, A.; Asano, N.; Kizu, H.; Matsui, K. J. Nat. Prod.
1997, 60, 312–314.
€
5. (a) Andersen, S. M.; Ekhart, C.; Lundt, I.; Stutz, A. E.
Carbohydr. Res. 2000, 326, 22–33; (b) Lemaire, M.; Veny,
With the accomplishment of the synthesis of 2, it is
obvious for us that 1R,4R,5R-triacetoxy-cyclohex-2-ene
3 can be easily prepared from the proper transforma-
tions of
D
-())-quinic acid (Scheme 2). Reports have
^
N.; Gefflaut, T.; Gallienne, E.; Chenevert, R.; Bolte, J.
Synlett 2002, 1359–1361.
6. McCasland, G. E.; Naumann, M. O.; Durham, L. J.
J. Org. Chem. 1968, 33, 4220–4227.
7. (a) McCasland, G. E.; Furuta, S.; Johnson, L. F.;
Shoolery, J. N. J. Am. Chem. Soc. 1961, 83, 2335–2343;
described the synthesis of ( )-proto-quercitol from the
racemic 3.8 Thus the chiral compound 3 can be used as a
crucial intermediate for synthesizing enantiomerically
pure (+)-proto-quercitol. Therefore, compound 6 was
acetylated to provide 14.19 The cyclohexyl groupof 14
was removed by 80% TFA (aq). Without further puri-
fication, the resulting diol was treated with thionyl
chloride20 to furnish 15 in 70% yield in a diastereomeric
mixture.21 Compound 1622 formed predominantly in
72% yield by heating 15 at 90 °C with sodium acetate in
DMF. It is noteworthy to mention that the elevated
temperature (>110 °C) and extended reaction time will
cause the low yields of 16 due to the aromatization of
15. The stereochemistry and regiochemistry of 16 were
further determined after its acetylation to provide 3 with
spectroscopic data in accordance with the reported
values.8b Therefore, our synthetic (+)-proto-quercitol23
was obtained by the known procedure, which converted
3 through 4.8b
€
(b) Maras, A.; Secen, H.; Sutbeyaz, Y.; Balci, M. J. Org.
Chem. 1998, 63, 2039–2041, and references cited therein.
€
8. (a) Secen, H.; Salamci, E.; Sutbeyaz, Y.; Balci, M. Synlett
1993, 609–610; (b) Salamci, E.; Secen, H.; Sutbeyaz, Y.;
€
€
Balci, M. J. Org. Chem. 1997, 62, 2453–2457; (c) Gultekin,
M. S.; Salamci, E.; Balci, M. Carbohydr. Res. 2003, 338,
1615–1619; For the synthesis of (+)-proto-quercitol see:
Hudlicky, T.; Thorpe, A. Synlett 1994, 899–901.
ꢀ
9. Colas, C.; Quiclet-Sire, B.; Cleophax, J.; Delaumeny,
J.-M.; Sepulchre, A.-M.; Gero, S. D. J. Am. Chem. Soc.
ꢀ
ꢀ
1980, 102, 857–858.
10. Chida, N.; Ohtsuka, K.; Nakazawa, K.; Ogawa, S. J. Org.
Chem. 1991, 56, 2976–2983.
11. Compound 6: clear syrup. 1H NMR (300 MHz, CDCl3): d
5.89 (br d, J ¼ 10:3 Hz, 1H), 5.71 (ddd, J ¼ 10:3, 4.4,
2.5 Hz, 1H), 4.35–4.50 (br m, 3H), 2.49 (dddd, J ¼ 13:9,
6.4, 3.7, 1.3 Hz, 1H), 1.66 (ddd, J ¼ 13:9, 9.5, 2.5 Hz, 1H),
1.48–1.60 (br m, 8H), 1.32–1.42 (br s, 2H). 13C NMR
(75 MHz, CDCl3): d 133.8, 127.4, 109.2, 72.2, 71.0, 63.3,
37.4, 35.8, 35.3, 25.1, 24.1, 23.9. MS (FAB) m=z 211
(Mþ+H, 38%), 193 (18%), 167 (32%), 99 (86%), 95 (100%).
12. Compound 7: clear syrup. 1H NMR (300 MHz, CDCl3): d
6.00 (dd, J ¼ 10:0, 4.7 Hz, 1H), 5.71 (dd, J ¼ 10:0, 2.2 Hz,
1H), 4.40–4.50 (m, 2H), 4.08 (dd, J ¼ 7:7, 4.1 Hz, 1H),
2.35 (dt, J ¼ 14:7, 3.9 Hz, 1H), 2.02 (ddd, J ¼ 14:7, 4.5,
2.3 Hz, 1H), 1.50–1.71 (m, 8H), 1.30–1.45 (br s, 2H). 13C
NMR (75 MHz, CDCl3): d 131.0, 127.3, 110.3, 72.6, 71.6,
62.8, 38.0, 35.9, 32.1, 25.0, 23.9, 23.8. MS (FAB) m=z 193
(Mþ+1)H2O, 55%), 147 (18%), 111 (33%), 70 (100%).
13. The determination of C-1 stereochemistry of both 6 and 7
has been reported while the isopropylidene group was used
In conclusion, we have accomplished the syntheses of a
new trihydroxy piperidine derivative 2 and (+)-proto-
quercitol from
Through the proper transformations of
acid, it is promising to synthesize not only this series of
piperidine derivatives but also the diastereomers of
quercitols in the future. The biological study of 2 and
employment of the key intermediates 6 and 7 for syn-
thesizing a variety of enantiomerically pure quercitols
are under investigation.
D
-())-quinic acid each in eleven steps.
-())-quinic
D
Acknowledgements
ꢀ
ꢀ
instead of the cyclohexyl group. Toth, Z. G.; Pelyvas, I. F.;
Szegedi, C.; Benke, P.; Magyar, E.; Miklovicz, T.; Batta,
G.; Sztaricskai, F. Carbohydr. Res. 1997, 300, 183–
189.
This work was financially supported from the National
Science Council (NSC92-2113-M-032-004) of the
Republic of China and Tamkang University.
14. Compound 8: pale yellow syrup. 1H NMR (300 MHz,
CDCl3): d 5.96 (dt, J ¼ 10:6, 2.5 Hz, 1H), 5.79 (dt,
J ¼ 10:6, 2.9 Hz, 1H), 4.60–4.69 (m, 1H), 4.40–4.53 (m,
2H), 2.51 (dt, J ¼ 14:0, 5.4 Hz, 1H), 2.10 (ddd, J ¼ 14:0,
8.4, 3.0 Hz, 1H), 1.53–1.60 (m, 8H), 1.32–1.45 (br s, 2H).
13C NMR (75 MHz, CDCl3): d 131.6, 128.0, 109.6, 71.7,
70.2, 51.6, 37.6, 35.8, 35.7, 25.0, 24.1, 23.8. MS (FAB) m=z
References and notes
1. (a) Paulsen, H. Angew. Chem., Int. Ed. Engl. 1966, 5, 495–
510; (b) Sinnott, M. L. Chem. Rev. 1990, 90, 1171–1202;
(c) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2,